| |
---|
| Detailed Price Information Link |
BACTERIA | How to read the following data (Example) |
Name: | "Corynebacterium urinapleomorphum" Niang et al. 2019 |
DSM No.: | 103272, Proposed type strain dsm-103272 dsm103272 dsm 103272 Corynebacterium urinapleomorphum |
Strain designation: | Marseille-P2799 |
Other collection no. or WDCM no.: | CSUR P2799 |
Isolated from: | Urine sample from patient analysed in Marseille |
Country: | France Marseille |
Date of sampling: | 20.04.2016 |
Nagoya Protocol Restrictions: | France requires a benefit-sharing declaration for French genetic resources at the time of utilization, i.e., conducting research. France considers access to genetic resources when utilization begins and not when the initial collection of the material took place and applies to material both in-situ and ex-situ and users within and outside of France.
To comply with French law, you, the user need to make a Declaration regarding access to genetic resources and benefit-sharing arising from your non-commercial utilisation of genetic resources. The steps are the following:
1. File a declaration via the CERFA form n. 15786 (https://www.formulaires.service-public.fr/gf/getAnnexe.do?cerfaAnnexe=1&cerfaFormulaire=15786*02) or by electronic procedure (https://www.demarches-simplifiees.fr/commencer/apa-declaration-pmorale)
2. Await approval by the Ministry for the Ecological Transition, the competent national authority
3. Respond to any requests for more information from the competent national authority
4. Receive an acknowledgment of receipt by the competent national authority certifying the prior informed consent (PIC) and establishment of mutually agreed terms (MAT) regarding benefit-sharing. This procedure shall not exceed 2 months.
For more information about this topic please see the Access and Benefit-Sharing Clearing House: https://absch.cbd.int/en/countries/FR
For more information about the commercial use of this genetic resources please contact: justiziariat@dsmz.de |
History: | <- F. Cadoret, CHU Hopital de la Timone, Fédération de Bactériologie Virologie Hygiène Hospitalière; Marseille-P2799 <- Unité de Recherche pour les Maladies Tropicales Emergentes, Fédération de Bactériologie Viorologie Hygiène Hospitalière; Marseille-P2799 |
Genbank accession numbers: | 16S rRNA gene: LT576404 whole genome shotgun sequence: FTLL00000000 |
Cultivation conditions: | Medium 535a , 37°C Medium/media recipe(s) required for preparing 535a: - Medium 535 or Medium 693 , 37°C
Incubation time: 2-3 days
Complete DSMZ Media List |
Summary and additional information: | <- F. Cadoret, CHU Hopital de la Timone, Fédération de Bactériologie Virologie Hygiène Hospitalière; Marseille-P2799 <- Unité de Recherche pour les Maladies Tropicales Emergentes, Fédération de Bactériologie Viorologie Hygiène Hospitalière; Marseille-P2799. Urine sample from patient analysed in Marseille; France, Marseille. Taxonomy/description (36452). Sequence accession no. 16S rRNA gene: LT576404, whole genome shotgun sequence: FTLL00000000. Strain Marseille-P2799 contains several rrn operons. (Medium 535a, 37°C or Medium 693). |
Literature: | 36452 |
Image: | ###IMAGE_TPL### Medium 535a 37°C Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH |
Risk group: | 1 (provisional classification by DSMZ) |
Supplied as: | Delivery form | | Prices | | Freeze Dried | | 100,- € | Active culture on request | | 240,- € | DNA | | 150,- € | | Price Category for this culture: 1 |
Freight and handling charges will be added. See price list. |
Other cultures: | All DSMZ cultures of the species |
| Print data sheet |